Q-omics provides the consensus-scored MIR4644 profile across patient tissues and cancer cell-line models. MIR4644 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, MIR4644 is differentially expressed in 10, with the highest sampling consensus in HNSC. Additionally, MIR4644 RNA expression shows 7,017 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight UVM, HNSC, and ACC as cancer lineages where MIR4644 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4644 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4644 survival associations across molecular data types. MIR4644 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4644 RNA expression–survival associations across cancer types. High MIR4644 expression shows unfavorable associations in UVM, KIRC, ESCA, SKCM, ACC and UCEC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for MIR4644 RNA expression.
This table summarizes MIR4644 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4644. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4644 shows lower tumor expression in KICH and higher tumor expression in HNSC, LUAD, BRCA, LUSC and CHOL. The HNSC box plot shows higher MIR4644 RNA expression in tumor versus normal tissue (log2 FC = +0.377, t-test p < 0.001).
This table shows molecular features associated with MIR4644 in patient tissues and cancer cell lines. In patient samples, MIR4644 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
